





















and,	 thus,	 potential	 therapeutic	 targets,	 of	 breast	 cancer	 metastasis.	 Ion	 channel	
dysregulation	 may	 be	 crucial	 in	 cancer	 development	 via	 the	 regulation	 of	 cancer	 cell	
characteristics	 such	 as	 migration,	 invasion	 and	 proliferation.	 Ion	 channels,	 such	 as	 the	
epithelial	 sodium	 channel	 (ENaC),	 may	 regulate	 the	 important	 process	 for	 metastasis	
development	 of	 epithelial-mesenchymal	 transition	 (EMT),	 which	 involves	 a	 change	 of	 cell	
phenotype	whereby	 cells	 lose	 their	 epithelial	 characteristics	 and	exhibit	 a	more	migratory	
phenotype.	There	 is	 limited	research	 investigating	the	role	of	ENaC	in	breast	cancer	or	the	
effect	of	ENaC	on	EMT.	Therefore,	the	aim	of	this	research	is	to	investigate	the	role	of	ENaC	



























Second,	 thank	 you	 to	 my	 advisor,	 Dr	 Heather	 Cunliffe,	 for	 teaching	 me	 the	 migration	
techniques,	providing	cells	for	this	project,	and	for	letting	me	become	part	of	your	lab	for	a	
few	months.		





the	 Boyden	 chamber	 migration	 technique.	 To	 Josh	 Harris,	 first,	 thank	 you	 for	 granting	










































































































































































%		 	 	 percent		
+	 	 	 plus		
<	 	 	 less	than		
=		 	 	 equals		
>	 	 	 more	than	
~		 	 	 approximately	
ASCL1	 	 	 achaete-scute	homolog	1		
ASIC1		 	 	 acid-sensing	ion	channel	1	
BKCa	 	 	 calcium	activated	K+-channel	
c	 	 	 concentration		
Ca2+		 	 	 calcium	ion		
CAD	1		 	 	 cadherin	1	or	E-cadherin		
CAD	2		 	 	 cadherin	2	or	N-cadherin	
cDNA		 	 	 complementary	deoxyribonucleic	acid	
cm2	 	 	 centimetre	squared		
CO2	 	 	 Carbon	dioxide		
CT		 	 	 cycle	threshold			
DNA		 	 	 deoxyribonucleic	acid	
EMT	 	 	 epithelial-mesenchymal	transition		
ENaC		 	 	 epithelial	sodium	channel			
ER		 	 	 oestrogen	receptor	
FBS		 	 	 Foetal	Bovine	Serum		
GAPDH		 	 Glyceraldehyde	3-phosphate	dehydrogenase	
H+		 	 	 hydrogen	ion	
H2O	 	 	 water		
Her2		 	 	 human	epidermal	growth	factor	2	receptor		
	 xiv	
hrs		 	 	 hour(s)		
K+		 	 	 potassium	ion		
L		 	 	 litre		
min	 	 	 minute(s)			
mL	 	 	 millilitre		
mM	 	 	 millimole			
mm2	 	 	 millimetre	squared	
mRNA	 	 	 messenger	ribonucleic	acid		
N		 	 	 number	of	biological	repeats		
n	 	 	 number	of	technical	repeats		
Na+	 	 	 sodium	ion		
nM	 	 	 nanomole	
ng	 	 	 nanogram	
o	 	 	 degree	
oC	 	 	 degrees	Celsius		
PBS		 	 	 phosphate-buffered	saline	
PR	 	 	 progesterone	receptor		
PTEN	 	 	 phosphatase	and	tensin	homolog		
RCF		 	 	 relative	centrifugal	force	
RNAse			 	 ribonuclease		
RPMI	 	 	 Roswell	Park	Memorial	Institute	
RT-qPCR		 	 real-time	quantitative	polymerase	chain	reaction	
s	 	 	 seconds		
SEM		 	 	 standard	error	of	the	mean		
SGK1	 	 	 serum	and	glucocorticoid-regulated	kinase		
siRNA	 	 	 small	interfering	ribonucleic	acid	
TRPV2			 	 Transient	receptor	potential	cation	channel	subfamily	V	member	2	
	 xv	
v		 	 	 volume		
VIM	 	 	 vimentin		
x		 	 	 times		
a	 	 	 alpha		
b	 	 	 beta	
d		 	 	 delta	
g	 	 	 gamma		
µg	 	 	 micrograms		
µL	 	 	 microlitre	
µM	 	 	 micromole	






































subtype	 is	 linked	to	patient	outcome	prognosis	with	certain	subtypes	resulting	 in	a	poorer	




The	 treatment	of	breast	 cancer	 in	New	Zealand	 is	 individualised	 to	 the	patient	 involving	a	
combination	of	surgery,	chemotherapy,	radiotherapy	and	hormonal	therapy	(Breast	Cancer	
Foundation	 NZ,	 2018b).	 In	 recent	 years	 there	 has	 been	 a	 shift	 to	 using	 more	 targeted	
treatments	 such	 as	 utilising	 the	 patient’s	 immune	 system	 to	 target	 cancer	 cells	 with	
immunotherapy	 (Nathan	&	Schmid,	2018).	Breast	cancer	patients	have	benefited	 the	 least	
from	 the	 advancements	 of	 immunotherapy	 because	 of	 the	 vast	 inter-	 and	 intra-tumour	
heterogeneity	 (Nathan	 &	 Schmid,	 2018),	 thus	 research	 into	 new	 targeted	 treatments	 is	
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In	order	 to	understand	 the	manner	 in	which	 ion	 channels	may	be	 suitable	as	 targets,	 it	 is	
important	 to	understand	 the	hallmarks	of	 cancer.	A	pinnacle	 review	 in	 the	 field	of	 cancer	

























(Heerboth	 et	 al.,	 2015).	 In	 EMT,	 the	 cells’	 features	 change	 from	 those	 that	 are	 typical	 of	
epithelia,	 including	 polygonal	 morphology,	 apical-basolateral	 polarity,	 strong	 cell-to-cell	






cells	 change	phenotype.	 The	 transition	 from	an	epithelial	phenotype	characterised	by	 cell	
polarity,	 interactions	 between	 cells	 and	 the	 extracellular	 matrix,	 to	 a	 mesenchymal	
phenotype.	
EMT	is	characterised	by	a	decrease	in	epithelial-specific	gene	expression	such	as	E-cadherin	














and	 cell	 death	 (Lang	 &	 Stournaras,	 2014).	 In	 breast	 cancer	 an	 investigation	 into	 gene	
expression	 showed	 between	 22	 and	 30	 genes	with	 differential	 expression	 of	multiple	 ion	
channel	 genes	 (Ko	 et	 al.,	 2013).	 Of	 the	 genes	 identified,	 alpha-ENaC	 showed	significant	
differential	mRNA	expression	in	breast	cancers	with	a	change	in	p53	mutation	status,	ER	status	
and	histological	grade	(Ko	et	al.,	2013).	However,	no	further	information	was	reported	on	the	
direction	 of	 alpha-ENaC	 expression	 change	 (up	 or	 down)	 or	 any	 implications	 of	 this	
observation.	




The	 acid-sensing	 ion	 channel	 1	 (ASIC1)	 is	 in	 the	 same	 superfamily	 as	 ENaC	 and	 is	
predominately	 involved	 in	 the	 flux	 of	 Na+	 ions;	 however,	 ASIC1	 is	 proton-activated	
(Hanukoglu,	2017).	ASIC1	 is	expressed	 in	breast	cancer	cell	 lines	and	 its	 inhibition	 led	 to	a	
reduction	of	tumour	growth	in	a	xenograft	model	(Gupta	et	al.,	2016).	Furthermore,	Gupta	
(2016)	determined	that	 inhibition	of	 factors,	such	as	NF-κB,	contribute	to	a	cell’s	ability	 to	
migrate.	Another	Na+	channel,	Nav1.5,	has	been	associated	with	the	 invasiveness	of	breast	
cancer	cells,	with	more	invasive	cell	lines	having	higher	levels	of	Nav1.5	mRNA	(Brisson	et	al.,	





calcium	 channels	 being	 regulators	 of	 filopodia,	 finger-like	 actin-rich	 protrusions	 from	 the	
membrane	that	assemble	at	the	front	of	migrating	cancer	cells,	which	are	required	for	cell	








One	possible	mechanism	 through	which	 ion	 channels	have	a	 regulatory	 role	 in	 cancer	 cell	
migration	is	during	epithelial-to-mesenchymal	transition	(EMT).	Ion	channels	(and	changes	in	
their	expression)	can	influence	some	of	the	identified	factors	that	affect	whether	a	cancer	cell	
undergoes	 EMT	 such	 as	 extracellular	 and	 intracellular	 signalling,	 cancer	 progenitor	 cell	
characteristics	 and	 the	 cellular	 environment	 (Heerboth	 et	 al.,	 2015).	 This	 leads	 to	 the	
hypothesis	 that	 ion	 channels	 can	 act	 as	 a	mechanism	 for	 regulating	 cancer	 cell	migration	
during	EMT.	For	example,	voltage-gated	sodium	channels	were	reviewed	by	Eren	et	al.	(2015)	

























subunits	 there	 are	 two	 cysteine-rich	 domains	 in	 the	 extracellular	 domain	 and	 on	 the	 C-	
terminal	there	 is	a	PY	motif	 that	 is	critical	 for	protein-to-protein	 interaction,	which	 itself	 is	
important	for	the	regulation	of	ENaC	(Snyder	et	al.,	1994).	The	stoichiometry	of	ENaC	has	been	
















have	apical	 and	basolateral	membranes	 that	are	maintained	as	 separated	 regions	by	 tight	
junctions	and	ENaC	is	located	on	the	lumen-facing	apical	membrane	(Hanukoglu	&	Hanukoglu,	
2016).	 The	 concentration	 of	 Na+	 ions	 in	 epithelial	 cells	 is	 low	 and	 this	 facilitates	 ENaC	 to	
reabsorb	Na+	from	the	lumen	across	the	apical	membrane	and	into	the	cell	(Koefoed-Johnsen	
&	 Ussing,	 1958).	 The	 intracellular	 concentration	 is	 maintained	 by	 the	 basolateral	 Na+/K+	
ATPase	 which	 actively	 transports	 Na+	 in	 across	 the	 basolateral	 membrane,	 therefore	 the	
concentration	of	Na+	ions	is	higher	in	the	lumen	creating	a	natural	concentration	gradient	of	
Na+	across	the	apical	membrane	which	is	utilised	by	ENaC	(Benos	et	al.,	1995).	The	location	of	
ENaC	 at	 the	 apical	 membrane	 allows	 for	 the	 sensing	 of	 changes	 in	 the	 extracellular	
environment	(Chifflet	&	Hernandez,	2016).	It	is	thought	that	ENaC	can	act	as	a	mechanosensor	
in	 some	 cells	 as	 the	 ion	 channel	 proteins	 are	 anchored	 to	 the	 extracellular	 matrix	 and	









Figure	 1.3:	 ENaC	 connects	 to	 the	 extracellular	 glycocalyx	 and	 intracellular	 cytoskeleton.	





ENaC	 has	 been	 identified	 as	 being	 expressed	 in	 mammary	 tissue	 which	 influenced	 the	
development	of	this	research	(Boyd	&	Náray-Fejes-Tóth,	2007).	As	described	above	the	role	
of	 ENaC	 is	 to	 allow	 the	passage	of	Na+	 ions	 through	 the	 apical	membrane	using	 the	 ions’	
concentration	gradient;	 therefore,	 it	 is	necessary	 for	 the	 reabsorption	of	Na+	and	 thus	 the	
homeostasis	 of	water	 in	 the	 body.	 Therefore,	 ENaC	 is	 able	 to	 regulate	 blood	 pressure	 by	
regulating	the	extracellular	fluid	volume	(Hanukoglu	&	Hanukoglu,	2016).		
Subsequently,	 the	dysregulation	or	disruption	of	 the	expression	of	ENaC	can	 lead	to	blood	
pressure-related	 conditions	 for	 instance,	 Liddle’s	 syndrome,	 an	 inherited	 form	 of	























is	 that	 it	 promotes	 trafficking	 of	 ENaC	 in	 the	 cell	 to	 the	 apical	membrane,	 resulting	 in	 an	
increased	amount	of	ENaC	expressed	in	the	cell,	and	decrease	the	endocytosis	of	ENaC	(Loffing	
et	al.,	2001;	Hanukoglu	&	Hanukoglu,	2016).	In	the	long	term	aldosterone	leads	to	an	increase	





ENaC	 are	 tissue	 specific	 and	 in	 breast	 cancer	 cells	 the	 beta	 and	 gamma	 subunits	 are	
upregulated	(Loffing	et	al.,	2001;	Boyd	&	Náray-Fejes-Tóth,	2007).	Research	has	shown	that	
the	 breast	 cancer	 line	 MDAMB231	 that	 is	 to	 be	 used	 in	 this	 project	 does	 respond	 to	















In	 recent	 years,	 research	 into	 the	 role	 of	 ENaC	 in	 cancerous	 cells	 has	 increased.	 It	 was	
identified	that	the	SCNN1	genes	are	involved	in	oncogenesis	because	the	formed	ENaC	protein	
contributes	to	several	cell	processes	(Li	et	al.,	2015).	 In	the	 literature,	a	 limited	number	of	
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removal	 of	 alpha	 ENaC	 also	 decreased	 cell	 volume,	 which	 is	 a	 sign	 of	 early	 apoptosis	
(Bondarava	et	al.,	2009).	A	recent	study	in	 lung	cancer	cells	found	alpha-ENaC	to	be	highly	















the	 Na+	 entry	 into	 the	 cell	 meant	 the	 cell	 was	 unable	 to	 swell,	 which	 is	 required	 for	
lamellipodium	expansion	in	migration	(Kapoor	et	al.,	2009).		





















There	 is	 limited	research	published	which	 investigates	ENaC’s	role	 in	breast	cancer	and	no	
























high	 alpha	 ENaC	 expression	 (Figure	 1.4)	 indicating	 a	 possible	 beneficial	 role	 of	 ENaC	
expression	for	improved	breast	cancer	prognosis.		
	




































1976 1137 472 111 13 2low     
1975 1382 603 130 14 1high     
HR = 0.73 (0.65 − 0.81)















It	was	hypothesised	 that	 the	blocking	of	ENaC	with	 the	administration	of	amiloride	would	
increase	the	breast	cancer	cells’	ability	to	undergo	EMT	and	therefore	migrate	faster.	On	the	
other	 hand,	 increasing	 ENaC	 expression	 with	 the	 administration	 of	 aldosterone	 would	
decrease	 the	 cancer	 cells’	 ability	 to	migrate.	 It	 was	 hypothesised	 that	 aldosterone	would	
change	 the	 levels	 of	 the	 ENaC	 subunit	 mRNA	 as	 it	 increases	 gene	 transcription	 whereas	
amiloride	would	have	no	effect	on	the	mRNA	present	in	the	cells.	If	the	role	of	ENaC	was	to	


















BT549	 cells	 are	 a	 human	 mammary	 gland/breast	 epithelial	 cell	 line.	 The	 cells	 are	 triple	







triple	negative	breast	 cancer	 cells	 and	phenotype	 shown	 in	Figure	2.1	B.	 These	 cells	were	
18	
	






























healthy	cells,	 the	author	 transferred	 to	 the	Cunliffe	 Laboratory	and	began	work	with	both	
BT549	and	MDAMB231	cell	lines	that	this	laboratory	had	growing.	Prior	to	passaging	the	cell	
media	(described	in	2.1.1),	0.25%	trypsin	EDTA	(Gibco™	Cat.	No.	25200056)	and	phosphate-
























point.	 The	 number	 of	 cells	 was	 calculated	 using	 Equation	 2.1	 to	 calculate	 the	 volume	 in	
microliters	of	cells	needed	to	achieve	the	density	of	cells	required.		
𝑣𝑜𝑙𝑢𝑚𝑒	 µL	 = 	
𝑑𝑒𝑛𝑠𝑖𝑡𝑦	𝑜𝑓	𝑐𝑒𝑙𝑙𝑠	𝑤𝑎𝑛𝑡𝑒𝑑/100	000	 300	000/100	000





The	 first	 migration	 assay	 used	 was	 a	 scratch	 assay	 or	 a	 wound-healing	 assay.	 This	 assay	
measures	the	migration	ability	of	cells	to	cover	over	a	scratch	portion	in	a	certain	amount	of	
time.	 The	 assay	 is	 completed	 in	 less	 time	 than	one	 cell	 cycle	 so	 that	 it	 is	 certain	 that	 the	








the	plate.	 The	 scratch	was	made	with	 a	 rounded	glass	pipette	 to	make	a	 cross	 in	 the	 cell	











a	 particular	 gene,	 knockdown	a	 gene	or	 overexpress	 it,	 is	 known	as	 cell	 transfection.	 This	
technique	was	used	to	overexpress	ENaC	subunits	from	the	pMT3	vector/plasmid	(alpha	alone	



























This	 method	 of	 overexpressing	 the	 ENaC	 subunits	 was	 not	 continued	 as	 preliminary	
experiments	indicated	the	cells	did	not	grow	well	when	incubated	with	serum	free	media	for	










































































as	 follows:	method:	 variance,	 variance	 filter	 radius:	 10,	 threshold:	 40,	 radius	 open:	 6	 and	














































The	 volume	of	 replete	media	 the	 cells	were	 resuspended	 in	 depended	on	 the	 treatments	






























Empty	 Empty	 Empty	 Empty	 Empty	 Empty	
2.5.1.1	Amiloride		
A	 final	 amiloride	 concentration	 of	 2	µM	and	 10	µM	of	 amiloride	was	 used,	matching	 the	



































































course	 experiment	 to	 investigate	 the	 length	 of	 incubation	 each	 cell	 line	would	 require	 to	
migrate	to	a	state	where	there	was	approximately	50%	coverage	of	the	image	viewed.			
Time	course	of	cell	migration	 for	each	cell	 line	was	 tested	 in	preliminary	experiments	 that	
were	terminated	at	1,	2	and	3	hr	of	incubation.	At	this	point,	the	cells	were	fixed	and	stained	
according	to	the	protocol	 in	2.7.3.	These	results	showed	that	a	longer	incubation	time	was	





However,	 the	 first	 actual	 experiment	 for	 the	 MDAMB231	 cell	 line	 showed	 that	 a	 5-hrs	
incubation	 resulted	 in	 too	 many	 cells	 migrating	 to	 count,	 therefore	 all	 subsequent	















ensuring	 no	 damage	 of	 the	 membrane.	 The	 cells	 that	 have	 not	 migrated	 through	 the	
membrane	were	removed	using	a	dry	Q-tip	on	the	inside	of	the	cup.	Following	this,	a	Q-tip	
soaked	 in	 PBS	was	 used	 to	 scrape	 the	 inside	 of	 the	 cup	 to	 ensure	 all	 cells	 on	 top	 of	 the	





























































RNA	Micro	 Prep	 extraction	 wQiagen	 RNeasy	 kit	 by	Mancini.,	 2013,	 was	 followed	 using	 a	
RNeasy	Mini	 Kit	 (Qiagen,	 Cat.	 No.	 74004,	Germany).	 Following	 this	method,	 the	 RNA	was	













experiment.	 This	 process	 involved	using	 chloroform	and	Qiagen	Micro-RNeasy	 columns	 to	
isolate	the	RNA	from	cells	and	this	resulted	in	20	µL	of	RNA.	The	samples	were	then	measured	
for	their	quality	and	concentration	of	RNA	using	2	µL	RNAse	free	water	as	a	blank	and	2	µL	of	
each	 sample.	 Absorbance	 of	 the	 sample,	 between	 260	nm	and	 280	nm,	was	 read	using	 a	
spectrophotometer	 (Synergy2,	 Biotek,	 USA).	 From	 this	 concentration	 measurement,	 the	






















































pipette	 into	 each	well	 to	 produce	 a	 10	µL	 total	 volume.	 An	 example	 of	 how	 a	 plate	was	
prepared	is	given	in	Table	2.4.	Each	gene	primer	set	for	a	particular	cDNA	sample	was	run	in	
a	triplicate.	

















	 Gene	1		 Gene	2		 Gene	3		 GAPDH		
Experiment	1	control	 o	 o	 o	 o	 o	 o	 o	 o	 o	 o	 o	 o	
Experiment	1	concentration	1	 o	 o	 o	 o	 o	 o	 o	 o	 o	 o	 o	 o	
Experiment	1	concentration	2	 o	 o	 o	 o	 o	 o	 o	 o	 o	 o	 o	 o	
Experiment	2	control		 o	 o	 o	 o	 o	 o	 o	 o	 o	 o	 o	 o	
Experiment	2	concentration	1	 o	 o	 o	 o	 o	 o	 o	 o	 o	 o	 o	 o	
Experiment	2	concentration	2	 o	 o	 o	 o	 o	 o	 o	 o	 o	 o	 o	 o	
















1	 95	 10	min	 1	 95	 10	min	
2	 95	 15	s	 2	 95		 15	s	




5	 95	 15	s	 5	 Repeat	2	to	4		 40	
times	














experiments,	 a	 one-way	 ANOVA	was	 used	with	 Dunnett’s	 post	 hoc	 test.	 For	 RT-qPCR,	 an	
unpaired	 Student’s	 t-test	 was	 used.	 For	 RT-PCR	 results	 the	 Grubb’s	 method	 to	 identify	
significant	outliers	was	used	and	these	were	removed.	A	capitalised	N	used	to	represent	the	











The	 aim	of	 this	 research	 project	was	 to	 investigate	 the	 role	 of	 ENaC	 in	 the	 cell	migration	




The	 first	 part	 of	 this	 results	 section	will	 describe	 the	 findings	 of	 experiments	where	 ENaC	
activity	 was	 inhibited	 by	 the	 addition	 of	 amiloride,	 or	 increased	 with	 aldosterone.	 Two	



























significant	 at	 8	hrs	 (p	<	0.01)	 and	12	hrs	 (p	<	0.0001),	whereas	with	10	µM	amiloride	 the	
difference	started	to	be	statistically	significant	at	5	hrs	(p	<	0.01)	and	again	at	8	hrs	(p	<	0.0001)	
and	12	hrs	(p	<	0.0001)	post	scratch	(Figure	3.1	G).	At	24	hrs	the	scratch	was	covered	in	all	














































































































Figure	 3.2:	 The	migration	of	MDAMB231	 cells	was	 slower	when	 ENaC	was	blocked	with	
amiloride	in	the	scratch	assay.	A)	Control	cells	at	0	hrs,	B)	control	cells	at	12	hrs,	C)	2	µM	
amiloride	treated	cells	at	0	hrs,	D)	2	µM	amiloride	treated	cells	at	12	hrs,	E)	10	µM	amiloride	
treated	 cells	 at	 0	 hrs,	 F)	 10	 µM	 amiloride	 treated	 cells	 at	 12	 hrs.	 Yellow	 outlines	 were	



























Following	 the	 results	 obtained	 in	 the	 scratch	 assay,	 a	 second	 type	of	migration	 assay	was	

















with	 BT549,	 see	 Appendix	 7.1).	 The	 images	 were	 quantified	 using	 an	 ImageJ	 macro	 to	
determine	 the	black:white	 ratio	which	was	obtained	by	 turning	any	purple	staining	 (which	
reflected	migrated	cells)	in	the	image	to	black	pixels	and	this	was	compared	to	the	white	pixels	

















































BT549	 cells,	 at	 either	 concentration	 of	 amiloride	 (2	µM	 or	 10	µM)	 (Figure	 3.4	 A-D).	 The	

















Figure	 3.4:	 Amiloride	 did	 not	 affect	 BT549	 cell	 migration	 in	 Boyden	 chamber	 assay.	 A)	
Migrated	control	cells,	B)	migrated	2	µM	amiloride	cells,	C)	migrated	10	µM	amiloride	cells.	
Images	taken	with	a	10	x	objective	lens	following	the	Boyden	chamber	assay.	D)	Comparison	








































































chamber	 assay.	D)	 Comparison	of	 treatments;	 the	 area	of	 cells	 covered	 as	 determined	by	














































migration	 in	 most	 assays	 and	 cell	 lines	 examined,	 the	 opposite	 effect	 on	 ENaC	 was	
investigated.	ENaC	was	increased	to	examine	if	this	resulted	in	the	opposite	effect	of	faster	
migration.	 Aldosterone	 (see	 1.4.3.2)	 is	 a	 naturally	 occurring	 hormone	 in	 the	 body	 which	






amiloride	were	 reversed.	 The	 scratch	 assay	was	 repeated	with	 the	 BT459	 cell	 line	with	 a	
control	 of	 ethanol	 and	 two	 concentrations	 of	 aldosterone,	 5	 nM	 and	 10	 nM	 which	 are	
physiological	 relevant	 concentrations	 and	 have	 been	 used	 in	 previous	 research	 with	













































Figure	 3.6:	 The	migration	 of	 BT549	 cells	 was	 enhanced	 when	 ENaC	 was	 increased	 with	
aldosterone	 in	 scratch	 assay.	 A)	 Control	 cells	 at	 0	 hrs,	 B)	 control	 cells	 at	 12	hrs,	 C)	 5	 nM	






and	 5	 nM	 aldosterone,	 *	 p	 <	 0.05	 between	 control	 and	 10	 nM	 aldosterone	 showing	 a	
statistically	significant	difference.	
























was	 observed;	 therefore,	 increasing	 ENaC	with	 aldosterone	was	 hypothesised	 to	 enhance	
migration.	 Converse	 to	 the	 BT549	 cells	 line,	 the	 MDAMB231	 cell	 line	 migration	 was	 not	
enhanced	 in	 the	 presence	 of	 aldosterone	 (Figure	 3.7	 A-F).	 Unexpectedly,	 for	 both	
concentrations	of	aldosterone	there	was	a	decreased	cell	migration	and	this	difference	from	
the	 control	 was	 noticeable	 as	 early	 as	 8	 hrs.	 At	 8	 hrs	 there	 was	 for	 5	 nM	 aldosterone	 a	












































































scratch	 assays,	 Boyden	 chambers	 were	 additionally	 used	 to	 investigate	 the	 effect	 of	
aldosterone	 on	 migration.	 For	 the	 BT549	 cell	 line,	 the	 presence	 of	 5	 nM	 and	 10	 nM	
aldosterone	 visibly	 increased	 the	 number	 of	 cells	 that	 migrated	 through	 the	 membrane	
(Figure	3.8	A-C).	Four	trials	of	the	Boyden	chambers	were	conducted	and	these	showed	that	
there	was	 a	 statistically	 significant	 difference	 in	 black:white	 ratio	 for	 the	 number	 of	 cells	
















Boyden	 chamber	 assay.	A)	Migrated	 control	 cells,	 B)	migrated	 5	 nM	 aldosterone	 cells,	 C)	









cell	 line	resulted	 in	an	 increased	migration	 in	 the	Boyden	chamber	assay.	The	MDAMB231	
cells	 with	 increased	 ENaC	 with	 the	 addition	 of	 aldosterone	 displayed	 a	 trend	 towards	























































Boyden	 chamber	 assay.	 A)	Migrated	 control	 cells,	 B)	migrated	 5	 nM	 aldosterone	 cells,	 C)	
migrated	 10	 nM	 aldosterone	 cells.	 Images	 taken	with	 a	 10	 x	 objective	 lens	 following	 the	
Boyden	chamber	assay.	D)	Comparison	of	treatments;	area	of	cells	covered	as	determined	by	









































































































3.7	 RT-qPCR	 Results	 Demonstrating	 the	 Impact	 of	 Amiloride	
and	Aldosterone	on	mRNA	level	of	ENaC	Subunits	and	Markers	
of	EMT	in	the	BT549	Cell	Line	




expression	 usually	 seen	 in	 epithelial	 compared	with	 the	mesenchymal	 phenotypes.	 It	was	
hypothesised	that	there	would	be	no	changes	in	ENaC	mRNA	levels	with	amiloride	treatment	


















































































































Figure	 3.11:	 mRNA	 expression	 of	 EMT	 markers	 with	 treatment	 of	 either	 amiloride	 or	
aldosterone.	 A)	 BT549	 cells	 collected	 after	 amiloride	 scratch	 experiments	 and	 mRNA	










































































process.	 ENaC	 is	 a	 heterotrimeric	 sodium	 ion	 channel	 present	 on	 the	 apical	 surface	 of	
polarised	epithelia	such	as	mammary	epithelia	(Boyd	&	Náray-Fejes-Tóth,	2007;	Hanukoglu	&	
Hanukoglu,	 2016).	 The	 alpha	 subunit	 of	 ENaC	 has	 been	 shown	 to	 have	 differential	mRNA	
expression	in	many	breast	cancer	subtypes	using	a	microarray	meta-analysis	(Ko	et	al.,	2013).	
Ion	 channels,	 including	 ENaC,	 have	 been	 identified	 as	 possible	 targets	 for	 new	 cancer	
treatments	 (Li	 &	 Xiong,	 2011).	 This	 is	 due	 to	 the	 fundamental	 role	 ion	 channels	 play	 in	
regulating	 cell	 functions,	 particularly	 tumour	 cell	 functions	 such	 as	 cell	 migration,	 cell	
proliferation,	 cell	 volume	 regulation	 and	 cell	 death	 (Lang	 &	 Stournaras,	 2014).	 Heerboth	



















For	many	years	now,	amiloride	has	been	established	as	an	 inhibitor	of	Na+	 transport	 as	 it	
inhibits	ENaC	at	low	concentrations	by	binding	to	the	channel	pore	(Kleyman	&	Cragoe,	1988;	
Kashlan	&	Kleyman,	2011).	For	this	reason,	amiloride	was	used	 in	this	study	to	block	ENaC	












The	MDAMB231	cell	 line	also	displayed	a	statistically	 significant	slower	migration	with	 the	
higher	concentration	of	10	µM	amiloride.	At	the	lower	concentration	of	2	µM	amiloride	there	





















The	 doubling	 time	 for	 BT549	 and	 MDAMB231	 cells	 is	 approximately	 25	 hrs,	 with	 some	


























migrated	 through	 the	 membrane	 and	 were	 stained.	 This	 result	 was	 in	 contrast	 to	 the	
significant	 reduction	 in	 migration	 seen	 in	 the	 scratch	 assay.	 On	 the	 other	 hand,	 the	











variability	means	 further	 trials	are	needed	to	observe	a	definitive	effect	of	 the	addition	of	
amiloride.	A	possible	cause	of	the	variability	was	the	seeding	of	slightly	differing	numbers	of	
cells	into	the	well	during	the	assay	set-up.	During	experimentation,	a	meticulous	effort	was	



































are	 aligned	 with	 other	 studies	 of	 ENaC	 and	 migration.	 There	 are	 a	 few	 hypothesised	


























































these	 hormones	may	 impact	 on	 ENaC	 expression	 and	 activity.	 Therefore,	 future	 research	
should	seek	to	reduce	the	effect	of	these	other	hormones	in	the	migration	assays	undertaken.	







aligned	 with	 the	 results	 of	 amiloride	 as	 the	 opposite	 effect	 was	 seen,	 suggesting	 that	















hrs	 time	point,	as	seen	 in	 the	result	of	 this	assay.	 In	 future	research	an	assessment	of	 the	
mRNA	expression	of	ENaC	with	aldosterone	at	the	same	time	points	assessed	in	the	scratch	
assay	would	be	recommended	to	determine	if	the	effect	of	aldosterone	occurs	at	each	time	
point.	This	would	confirm	if	the	observed	delay	 in	cell	migration	was	due	to	an	 increase	 in	
ENaC	as	a	result	of	the	mechanism	of	action	of	aldosterone.		
The	MDAMB231	cell	line	unpredictably	did	not	follow	the	same	trend	as	the	BT549	cell	line	
with	 the	administration	of	 aldosterone.	 The	addition	of	 aldosterone	 resulted	 in	 significant	
reduction	in	migration	ability	at	5,	8	and	12	hrs	for	the	10	nM	aldosterone.	This	is	the	identical	
effect	that	was	observed	when	blocking	ENaC	with	amiloride	in	this	cell	line,	which	indicates	


















Another	 possibility	 is	 the	 treatments	 of	 aldosterone	 and	 amiloride	 have	 off-target	 effects	




























which	 ENaC	 influences	 migration	 has	 been	 given	 in	 section	 4.2	 (also	 see	 Figure	 4.1).	
Aldosterone	has	been	shown	in	these	results	to	increase	the	number	of	ENaC	present	at	the	
cell	membrane,	 therefore	 it	 can	 be	 concluded	 that	 aldosterone	 causes	 an	 increase	 in	Na+	












it	 was	 hypothesised	 that	 blocking	 ENaC	 with	 amiloride	 would	 result	 in	 the	 increase	 of	








fold	 change	 in	 mRNA	 expression	 with	 either	 the	 beta	 or	 gamma	 subunits.	 However,	 a	
significant	decrease	in	fold	expression	in	the	alpha	subunit	was	observed.	This	was	surprising	
as	there	should	not	have	been	an	effect	on	mRNA	levels	with	amiloride	treatment.	







tissue	 (Renard	 et	 al.,	 1995;	 Boyd	 &	 Náray-Fejes-Tóth,	 2007).	 As	 there	 was	 no	 observed	
increase	in	ENaC	subunits	with	aldosterone,	in	future	experiments	the	mRNA	of	Serum	and	

















were	 reduced	mRNA	 levels.	 There	was	 also	 a	 statistically	 significant	 slight	 decrease	 in	 N-
cadherin	 with	 10	 µM	 amiloride;	 however,	 this	 was	 not	 a	 sizable	 decrease	 to	 conclude	 a	
75	
	










on	 migration,	 however,	 it	 appeared	 that	 blocking	 ENaC	 caused	 the	 cell	 to	 increase	 its	





are	 visualised	 to	 be	migrating	 to	 assess	 if	 the	 EMT	markers	 change	when	 cells	 undertake	
migration.		
The	 results	 presented	 in	 this	 thesis	 align	 with	 the	 debated	 ‘go	 or	 grow’	 theory,	 which	
hypothesises	that	cells	can	defer	proliferation	for	migration.	This	theory	is	based	on	the	idea	
that	 genetic	 and	 cytoskeletal	 machinery	 cannot	 be	 concurrently	 used	 for	 migration	 and	
proliferation	(Garay	et	al.,	2013).	The	mutual	exclusiveness	of	these	two	cellular	processes	is	





a	 temporal	 separation	 between	 proliferation	 and	migration,	 but	 a	 tumour	 can	 have	 both	
occurring	simultaneously	(Garay	et	al.,	2013).	Hence	highly	invasive	tissues	can	also	have	high	






future	 research.	 The	 amiloride	 and	 aldosterone	 treatments	 were	 used	 in	 the	 migration	
experiments	owing	to	complications	during	early	experimentation	as	attempts	to	overexpress	
ENaC	with	transient	transfection	resulted	in	cells	dying.	To	build	on	this	project’s	results,	the	
next	 step	 would	 be	 to	 use	 overexpression	 and	 siRNA	 knockdown	 of	 ENaC	 subunits	 to	
investigate	if	corresponding	effects	are	seen	in	migration	ability.	Any	other	off-target	effects	
of	the	treatments	used	in	this	project	would	be	eliminated,	therefore	isolating	the	effect	of	
changes	 in	ENaC	expression	 in	 the	results.	This	project	 focused	on	the	 investigation	of	cell	
migration,	which	 is	only	one	of	 the	aspects	a	 cancer	 cell	undergoes	 in	metastasis.	 Further	
research	 is	 required	 to	 study	 the	 effect	 of	 ENaC	 on	 cell	 invasion	with	 a	Matrigel	 Boyden	







To	 further	 the	 understanding	 of	 ENaC	 in	 EMT,	 more	 extensive	 research	 with	 RT-qPCR	 is	
recommended	 to	 examine	 the	 effect	 of	 changing	 ENaC	 on	 EMT	 markers	 but	 also	 with	
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amiloride	 in	 Boyden	 chamber	 assay	 with	 migration	 showing	 the	 area	 of	 cells	 covered	 as	
determined	by	black:white	ratio	for	each	treatment.	B)	MDAMB231	cell	line	variability	within	
one	biological	 trial	with	control,	2	µM	amiloride	and	10	µM	amiloride	 in	Boyden	chamber	
assay	with	migration	showing	the	area	of	cells	covered	as	determined	by	black:white	ratio	for	
each	treatment.	Data	shown	as	mean	±SEM.	One-way	ANOVA	with	Dunnett’s	post	hoc	test	
was	performed,	resulting	in	no	significant	difference,	p	>	0.05.	N	=	16	per	treatment	group.		
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Appendix	7.3:	Variability	within	Aldosterone	Data	in	Boyden	Chamber	
Assay	
A	
	
	
	
B	
	
	
	
	
A)	BT549	cell	line	variability	within	one	biological	trial	with	control,	5	nM	aldosterone	and	10	
nM	aldosterone	in	Boyden	chamber	assay	with	migration	showing	the	area	of	cells	covered	as	
determined	by	black:white	ratio	for	each	treatment.	B)	MDAMB231	cell	line	variability	within	
one	biological	trial	with	control,	5	nM	aldosterone	and	10	nM	aldosterone	in	Boyden	chamber	
assay	with	migration	showing	the	area	of	cells	covered	as	determined	by	black:white	ratio	for	
each	treatment.	Data	shown	as	mean	±SEM.	One-way	ANOVA	with	Dunnett’s	post	hoc	test	
was	performed,	**	p	<	0.01,	***	p	<	0.001	****	p	<	0.0001.	N	=	16	per	treatment	group.		
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